FIELD: medicine.
SUBSTANCE: invention relates to the use of N'-{1-[6-methyl-3-(thietan-3-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]propan-2-ylidene} isonicotinohydrazide as a means of stimulating tissue regeneration and wound healing.
EFFECT: regenerating properties for healing linear wounds and more effectively restoration of the skin properties.
1 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EYE OINTMENT BASED ON 6-METHYL-3-(THIETAN-3-YL)URACIL WITH WOUND-HEALING EFFECT | 2019 |
|
RU2705392C1 |
| SUBSTITUTED (2R,3R,5R)-3-HYDROXY-(5-PYRIMIDIN-1-YL)TETRAHYDROFURAN-2-YLMETHYL ARYL PHOSPHORAMIDATES | 2013 |
|
RU2553996C1 |
| 6-METHYL-1-(1-OXOTHIETAN-3-YL)URACIL, HAVING HYPOTENSIVE ACTIVITY | 2013 |
|
RU2536683C1 |
| ETHYLIDENE HYDRAZIDE OF 2-[6-METHYL-1-(THIETHAN-3-YL)URACYL-3-YL]ACETIC ACID, DEMONSTRATING HYPOTENSIVE ACTIVITY | 2013 |
|
RU2539301C1 |
| 6-METHYL-5-MORPHOLYNOMETHYL-1-(THIETHAN-3-YL)PYRIMIDINE-2,4(1H,3H)-DIONE, DEMONSTRATING ANTIOXIDANT ACTIVITY | 2013 |
|
RU2539302C1 |
| ANTITUMOUR AGENT INTENSIFIER | 2010 |
|
RU2548913C2 |
| DERIVATIVES OF 2,5-DIOXOIMIDAZOLIDINE-1-YL-3-PHENYLUREA AS MODULATORS OF FORMYLPEEPTITIDE RECEPTOR 1 (FPRL-1) | 2012 |
|
RU2645673C2 |
| 2-[6-METHYL-4-(THIETAN-3-YLOXY)PYRIMIDIN-2-YLTHIO]ACETOHYDRAZIDE OF MALEIC ACID HAVING ANTIMICROBIAL ACTIVITY | 2018 |
|
RU2671573C1 |
| 6-METHYL-1-(THIETANYL-3)URACIL STIMULATING PROTECTIVE ACTIVITY OF PHAGOCYTES | 2012 |
|
RU2485118C1 |
| NUCLEOTIDES INCLUDING N-[(S)-1-CYCLOBUTOXYCARBONYL]PHOSPHORAMIDATE FRAGMENT, THEIR ANALOGS AND THEIR APPLICATION | 2017 |
|
RU2659388C1 |
